Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey de Rocca Serra

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cellular and Molecular Life Sciences : CMLS|January 27, 2019
The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathwaysEmeline Bollaert, Audrey de Rocca Serra, Jean-Baptiste Demoulin
European Journal of Medical Genetics|September 6, 2015
SHP2 sails from physiology to pathologyMylène Tajan, Audrey de Rocca Serra, Philippe Valet, et al.
FEBS Open Bio|March 14, 2017
PDGF-induced fibroblast growth requires monounsaturated fatty acid production by stearoyl-CoA desaturaseAlexandra Coomans de Brachène, Nicolas Dif, Audrey de Rocca Serra, et al.
Cellular Signalling|January 23, 2018
HBP1 phosphorylation by AKT regulates its transcriptional activity and glioblastoma cell proliferationEmeline Bollaert, Manuel Johanns, Gaëtan Herinckx, et al.
The Biochemical Journal|April 26, 2014
The expression of the tumour suppressor HBP1 is down-regulated by growth factors via the PI3K/PKB/FOXO pathwayAlexandra Coomans de Brachène, Emeline Bollaert, Astrid Eijkelenboom, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 16, 2018
The gut microbiota metabolite indole alleviates liver inflammation in miceMartin Beaumont, Audrey M Neyrinck, Marta Olivares, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 29, 2012
Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short statureAudrey De Rocca Serra-Nédélec, Thomas Edouard, Karine Tréguer, et al.
Human Molecular Genetics|March 24, 2017
PDGFRB gain-of-function mutations in sporadic infantile myofibromatosisFlorence A Arts, Raf Sciot, Bénédicte Brichard, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesityMylène Tajan, Aurélie Batut, Thomas Cadoudal, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cellular and Molecular Life Sciences : CMLS|January 27, 2019
The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathwaysEmeline Bollaert, Audrey de Rocca Serra, Jean-Baptiste Demoulin
European Journal of Medical Genetics|September 6, 2015
SHP2 sails from physiology to pathologyMylène Tajan, Audrey de Rocca Serra, Philippe Valet, et al.
FEBS Open Bio|March 14, 2017
PDGF-induced fibroblast growth requires monounsaturated fatty acid production by stearoyl-CoA desaturaseAlexandra Coomans de Brachène, Nicolas Dif, Audrey de Rocca Serra, et al.
Cellular Signalling|January 23, 2018
HBP1 phosphorylation by AKT regulates its transcriptional activity and glioblastoma cell proliferationEmeline Bollaert, Manuel Johanns, Gaëtan Herinckx, et al.
The Biochemical Journal|April 26, 2014
The expression of the tumour suppressor HBP1 is down-regulated by growth factors via the PI3K/PKB/FOXO pathwayAlexandra Coomans de Brachène, Emeline Bollaert, Astrid Eijkelenboom, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 16, 2018
The gut microbiota metabolite indole alleviates liver inflammation in miceMartin Beaumont, Audrey M Neyrinck, Marta Olivares, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 29, 2012
Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short statureAudrey De Rocca Serra-Nédélec, Thomas Edouard, Karine Tréguer, et al.
Human Molecular Genetics|March 24, 2017
PDGFRB gain-of-function mutations in sporadic infantile myofibromatosisFlorence A Arts, Raf Sciot, Bénédicte Brichard, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesityMylène Tajan, Aurélie Batut, Thomas Cadoudal, et al.
Pageof 1